Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions.

β-Site amyloid precursor protein-cleaving enzyme-1 (BACE1) is a protease essential for amyloid-β (Aβ) production in Alzheimer's disease (AD). BACE1 protein is known to be up-regulated by oxidative stress-inducing stimuli but the mechanism for this up-regulation still needs to be clarified. We have recently found that BACE1 is modified with bisecting N-acetylglucosamine (GlcNAc) by N-acetylglucosaminyltransferase-III (GnT-III, encoded by the Mgat3 gene) and that GnT-III deficiency reduces Aβ-plaque formation in the brain by accelerating lysosomal degradation of BACE1. Therefore, we hypothesized that bisecting GlcNAc would stabilize BACE1 protein on oxidative stress. In the present study, we first show that Aβ deposition in the mouse brain induces oxidative stress, together with an increase in levels of BACE1 and bisecting GlcNAc. Furthermore, prooxidant treatment induces expression of BACE1 protein in wild-type mouse embryonic fibroblasts (MEFs), whereas it reduces BACE1 protein in GnT-III (Mgat3) knock-out MEFs by accelerating lysosomal degradation of BACE1. We purified BACE1 from Neuro2A cells and performed LC/ESI/MS analysis for BACE1-derived glycopeptides and mapped bisecting GlcNAc-modified sites on BACE1. Point mutations at two N-glycosylation sites (Asn(153) and Asn(223)) abolish the bisecting GlcNAc modification on BACE1. These mutations almost cancelled the enhanced BACE1 degradation seen in Mgat3(-/-) MEFs, indicating that bisecting GlcNAc on BACE1 indeed regulates its degradation. Finally, we show that traumatic brain injury-induced BACE1 up-regulation is significantly suppressed in the Mgat3(-/-) brain. These results highlight the role of bisecting GlcNAc in oxidative stress-induced BACE1 expression and offer a novel glycan-targeted strategy for suppressing Aβ generation.

[1]  M. Staufenbiel,et al.  An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease , 2015, EMBO molecular medicine.

[2]  P. Wong,et al.  Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects , 2014, Journal of neurochemistry.

[3]  N. Chandel,et al.  ROS Function in Redox Signaling and Oxidative Stress , 2014, Current Biology.

[4]  S. Itohara,et al.  Single App knock-in mouse models of Alzheimer's disease , 2014, Nature Neuroscience.

[5]  Y. Wada,et al.  The Absence of Core Fucose Up-regulates GnT-III and Wnt Target Genes , 2014, The Journal of Biological Chemistry.

[6]  D. Nicholson,et al.  The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques , 2013, Acta Neuropathologica.

[7]  G. Ciccotosto,et al.  Mild Oxidative Stress Induces Redistribution of BACE1 in Non-Apoptotic Conditions and Promotes the Amyloidogenic Processing of Alzheimer’s Disease Amyloid Precursor Protein , 2013, PloS one.

[8]  Yong Shen,et al.  Depletion of GGA1 and GGA3 Mediates Postinjury Elevation of BACE1 , 2012, The Journal of Neuroscience.

[9]  C. Bouras,et al.  Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway. , 2012, Biochimica et biophysica acta.

[10]  Y. Sugita,et al.  Effect of bisecting GlcNAc and core fucosylation on conformational properties of biantennary complex-type N-glycans in solution. , 2012, The journal of physical chemistry. B.

[11]  E. Hall,et al.  Antioxidant therapies in traumatic brain and spinal cord injury. , 2012, Biochimica et biophysica acta.

[12]  T. M. Sivanandam,et al.  Traumatic brain injury: A risk factor for Alzheimer's disease , 2012, Neuroscience & Biobehavioral Reviews.

[13]  R. von Bernhardi,et al.  Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms. , 2012, Antioxidants & redox signaling.

[14]  R. Vassar,et al.  Cdk5 Protein Inhibition and Aβ42 Increase BACE1 Protein Level in Primary Neurons by a Post-transcriptional Mechanism , 2012, The Journal of Biological Chemistry.

[15]  N. Taniguchi,et al.  Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeutics. , 2011, BMB reports.

[16]  Y. Sugita,et al.  Structural diversity and changes in conformational equilibria of biantennary complex-type N-glycans in water revealed by replica-exchange molecular dynamics simulation. , 2011, Biophysical journal.

[17]  B. Strooper,et al.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.

[18]  D. Selkoe,et al.  Resolving controversies on the path to Alzheimer's therapeutics , 2011, Nature Medicine.

[19]  N. Packer,et al.  Identification of Glycan Structure Alterations on Cell Membrane Proteins in Desoxyepothilone B Resistant Leukemia Cells* , 2011, Molecular & Cellular Proteomics.

[20]  Alison Abbott,et al.  Dementia: A problem for our age , 2011, Nature.

[21]  P. Wong,et al.  Amyloid precursor protein processing and Alzheimer's disease. , 2011, Annual review of neuroscience.

[22]  E. Hall,et al.  Mitochondrial protection after traumatic brain injury by scavenging lipid peroxyl radicals , 2010, Journal of neurochemistry.

[23]  G. Tesco,et al.  Ubiquitin Regulates GGA3-mediated Degradation of BACE1* , 2010, The Journal of Biological Chemistry.

[24]  H. Cai,et al.  β‐Secretase‐1 elevation in transgenic mouse models of Alzheimer’s disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development , 2009, The European journal of neuroscience.

[25]  Y. Matsuoka,et al.  Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury , 2009, Nature Medicine.

[26]  M. Tabaton,et al.  The up‐regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α , 2009, Journal of neurochemistry.

[27]  M. Tajiri,et al.  Site‐specific analysis of N‐glycans on haptoglobin in sera of patients with pancreatic cancer: A novel approach for the development of tumor markers , 2008, International journal of cancer.

[28]  J. Gu,et al.  Branched N‐glycans regulate the biological functions of integrins and cadherins , 2008, The FEBS journal.

[29]  M. Mattson,et al.  Oxidative stress activates a positive feedback between the γ‐ and β‐secretase cleavages of the β‐amyloid precursor protein , 2007 .

[30]  J. Ringman,et al.  Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin , 2007, Proceedings of the National Academy of Sciences.

[31]  R. Tanzi,et al.  Depletion of GGA3 Stabilizes BACE and Enhances β-Secretase Activity , 2007, Neuron.

[32]  Naoyuki Taniguchi,et al.  Decoding sugar functions by identifying target glycoproteins. , 2006, Current opinion in structural biology.

[33]  D. Butterfield,et al.  Mutations in amyloid precursor protein and presenilin‐1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid β‐peptide (1–42), H2O2 and kainic acid: implications for Alzheimer's disease , 2006, Journal of neurochemistry.

[34]  B. Hyman,et al.  BACE Is Degraded via the Lysosomal Pathway* , 2005, Journal of Biological Chemistry.

[35]  I. Kohane,et al.  Gene regulation and DNA damage in the ageing human brain , 2004, Nature.

[36]  L. Tsai,et al.  BACE1 Suppression by RNA Interference in Primary Cortical Neurons* , 2004, Journal of Biological Chemistry.

[37]  S. Melov,et al.  Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts , 2003, Nature Cell Biology.

[38]  S. Kitazume,et al.  Alzheimer's β-secretase, β-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Naoyuki Taniguchi,et al.  Expression of α1‐6 fucosyltransferase in rat tissues and human cancer cell lines , 1997 .

[40]  J. Marth,et al.  Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction. , 1997, Glycobiology.

[41]  R. Cummings,et al.  Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins. , 1982, The Journal of biological chemistry.

[42]  N. Taniguchi,et al.  Protective effect of N-glycan bisecting GlcNAc residues on beta-amyloid production in Alzheimer's disease. , 2010, Glycobiology.

[43]  J. Blass.  The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha , 2009 .

[44]  M. Mattson,et al.  Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. , 2008, Journal of neurochemistry.

[45]  R. Tanzi,et al.  Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. , 2007, Neuron.

[46]  P. Wong,et al.  Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease , 2003, Nature Medicine.

[47]  S. Kitazume,et al.  Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  N. Hayashi,et al.  Expression of alpha1-6 fucosyltransferase in rat tissues and human cancer cell lines. , 1997, International journal of cancer.